Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;14(4):332-335.
doi: 10.6004/jadpro.2023.14.4.8. Epub 2023 May 1.

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor

Affiliations

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor

Amy Henderson et al. J Adv Pract Oncol. 2023 May.

Abstract

Patients with neuroendocrine malignancy with liver metastases are at risk for carcinoid heart disease which, if left unchecked, can lead to heart failure. This case study demonstrates a clinical situation in which an advanced practitioner performed a thorough workup consisting of lab work and imaging studies, including echocardiogram, cardiac MRI, and dotatate PET/CT, as well as outside record review and comprehensive physical exam. Early detection, intervention, and control of disease are paramount to prevent potentially life-limiting carcinoid heart disease.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Ga-68 dotatate PET/CT scan demonstrating innumerable FDG-avid masses of the liver, consistent with Mrs. R's known history of metastatic neuroendocrine malignancy.
Figure 2
Figure 2
This illustration is consistent with carcinoid heart disease. Note the metastatic tumors in the liver, endocardial plaques within the right ventricle, and thickening of tricuspid and pulmonary valves (Mayo Clinic, 2015). Used with permission from the Mayo Foundation for Medical Education and Research. All rights reserved.

References

    1. Bober, B., Saracyn, M., Kołodziej, M., Kowalski, Ł., Deptuła-Krawczyk, E., Kapusta, W.,…Bil, J. (2020). Carcinoid heart disease: How to diagnose and treat in 2020? Clinical Medicine Insights: Cardiology, 14, 1179546820968101. 10.1177/1179546820968101 - DOI - PMC - PubMed
    1. Grozinsky-Glasberg, S., Grossman, A. B., & Gross, D. J. (2015). Carcinoid heart disease: From pathophysiology to treatment--‘Something in the Way It Moves.’ Neuroendocrinology, 101(4), 263–273. 10.1159/000381930 - DOI - PubMed
    1. Jin, C., Sharma, A., Thevakumar, B., Majid, M., Al Chalaby, S., Takahashi, N., Tanious, A., Arockiam, A., Beri, N., & Amsterdam, E. (2020). Carcinoid heart disease: Pathophysiology, pathology, clinical manifestations, and management. Cardiology, 146(1), 65–73. 10.1159/000507847 - DOI - PubMed
    1. Kinney, R. E., Decker, R., Sundlof, D., Rizvi, M. A., & Schadler, K. (2020). Case report: Neuroendocrine tumor with cardiac metastasis. Frontiers in Cardiovascular Medicine, 7. 10.3389/fcvm.2020.596921 - DOI - PMC - PubMed
    1. Mayo Clinic. (2015). Mayo Clinic announces carcinoid heart disease clinic. https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases...

LinkOut - more resources